CYTEK BIOSCIENCES, INC. Investing Cash Flow
CYTEK BIOSCIENCES, INC. (CTKB) reported Investing Cash Flow of -$20.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $7.02M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$27.08M, a 386.49% decline year-over-year.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$1.84M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $18.92M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2025 was $10.12M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$82.97M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$93.89M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$55.91M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$20.06M 10-Q · filed 2026-08-05 | -$21.90M derived: sum of 3 quarters · filed 2026-08-05 | -$2.98M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$27.08M 10-Q · filed 2026-05-07 | -$28.92M derived: sum of 2 quarters · filed 2026-05-07 | -$10.00M derived: sum of 3 quarters · filed 2026-05-07 | -$26.41M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $17.08M derived: sum of 2 quarters · filed 2026-02-26 | $665.00K derived: sum of 3 quarters · filed 2026-08-05 | $10.12M 10-K · filed 2026-02-26 |
| 2025-09-30 | $18.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.51M derived: sum of 2 quarters · filed 2026-08-05 | $11.96M 10-Q · filed 2025-11-05 | -$51.47M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$16.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$6.96M 10-Q · filed 2026-08-05 | -$70.39M derived: sum of 3 quarters · filed 2026-08-05 | -$86.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $9.45M 10-Q · filed 2026-05-07 | -$53.98M derived: sum of 2 quarters · filed 2026-05-07 | -$69.79M derived: sum of 3 quarters · filed 2026-05-07 | -$67.77M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$63.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$79.24M derived: sum of 2 quarters · filed 2026-02-26 | -$77.22M derived: sum of 3 quarters · filed 2026-02-26 | -$82.97M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$15.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$13.79M derived: sum of 2 quarters · filed 2025-11-05 | -$19.54M 10-Q · filed 2025-11-05 | $9.53M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$3.73M 10-Q · filed 2025-08-06 | $25.33M derived: sum of 3 quarters · filed 2026-02-26 | $68.46M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$5.75M 10-Q · filed 2025-05-08 | $23.31M derived: sum of 2 quarters · filed 2026-02-26 | $66.44M derived: sum of 3 quarters · filed 2026-02-26 | $69.23M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $29.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $72.19M derived: sum of 2 quarters · filed 2026-02-26 | $74.98M derived: sum of 3 quarters · filed 2026-02-26 | -$93.89M 10-K · filed 2026-02-26 |
| 2023-09-30 | $43.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $45.91M derived: sum of 2 quarters · filed 2024-11-07 | -$122.96M 10-Q · filed 2024-11-07 | -$174.02M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$166.08M 10-Q · filed 2024-08-06 | -$217.15M derived: sum of 3 quarters · filed 2025-02-28 | -$218.30M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$168.87M 10-Q · filed 2024-05-08 | -$219.94M derived: sum of 2 quarters · filed 2025-02-28 | -$221.09M derived: sum of 3 quarters · filed 2025-02-28 | -$224.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$51.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$52.21M derived: sum of 2 quarters · filed 2025-02-28 | -$55.13M derived: sum of 3 quarters · filed 2025-02-28 | -$55.91M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$4.07M derived: sum of 2 quarters · filed 2023-11-14 | -$4.84M 10-Q · filed 2023-11-14 | -$23.14M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | -$2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$3.69M 10-Q · filed 2023-08-08 | -$21.99M derived: sum of 3 quarters · filed 2024-03-13 | -$23.30M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | -$780.00K 10-Q · filed 2023-05-09 | -$19.08M derived: sum of 2 quarters · filed 2024-03-13 | -$20.38M derived: sum of 3 quarters · filed 2024-03-13 | -$21.64M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | -$18.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$19.60M derived: sum of 2 quarters · filed 2024-03-13 | -$20.86M derived: sum of 3 quarters · filed 2024-03-13 | -$20.99M 10-K · filed 2024-03-13 |
| 2021-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$2.56M derived: sum of 2 quarters · filed 2022-11-09 | -$2.70M 10-Q · filed 2022-11-09 | -$2.90M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$1.39M 10-Q · filed 2022-08-10 | -$1.59M derived: sum of 3 quarters · filed 2023-03-01 | -$2.07M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$138.00K 10-Q · filed 2022-05-12 | -$341.00K derived: sum of 2 quarters · filed 2023-03-01 | -$815.00K derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$677.00K derived: sum of 2 quarters · filed 2023-03-01 | -$1.55M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$474.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.34M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$870.00K 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |